Itemoids

You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was "rapidly transferring manufacturing" across the Atlantic.